• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Large owner Argos Holdings Gp Llc converted options into 29,940,120 shares and sold $1,250,000,010 worth of shares (29,940,120 units at $41.75) (SEC Form 4)

    6/26/25 4:05:06 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $CHWY alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Argos Holdings GP LLC

    (Last) (First) (Middle)
    650 MADISON AVENUE

    (Street)
    NEW YORK NY 10022

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Chewy, Inc. [ CHWY ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    06/25/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A common stock, par value $0.01 06/25/2025 C 29,940,120 A (1) 29,940,120 I See footnotes(2)(3)
    Class A common stock, par value $0.01 06/25/2025 S 27,544,910 D $41.75 2,395,210 I See footnotes(2)(3)
    Class A common stock, par value $0.01 06/25/2025 S 2,395,210 D $41.75 0 I See footnotes(2)(3)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Class B common stock, par value $0.01 (1) 06/25/2025 C 29,940,120 (1) (1) Class A common stock, par value $0.01 29,940,120 (1) 189,758,441 I See footnotes(2)(3)
    1. Name and Address of Reporting Person*
    Argos Holdings GP LLC

    (Last) (First) (Middle)
    650 MADISON AVENUE

    (Street)
    NEW YORK NY 10022

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Argos Holdings L.P.

    (Last) (First) (Middle)
    650 MADISON AVENUE

    (Street)
    NEW YORK NY 10022

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    CIE Management IX Ltd

    (Last) (First) (Middle)
    650 MADISON AVENUE

    (Street)
    NEW YORK NY 10022

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    BC Partners Holdings Ltd

    (Last) (First) (Middle)
    650 MADISON AVENUE

    (Street)
    NEW YORK NY 10022

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Citrus Intermediate Holdings L.P.

    (Last) (First) (Middle)
    650 MADISON AVENUE

    (Street)
    NEW YORK NY 10022

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. Each share of Class A common stock was issued upon conversion of one share of Class B common stock. Shares of Class B common stock are convertible into shares of Class A common stock on a one-for-one basis.
    2. Argos Holdings GP LLC ("GP LLC") is the general partner of Argos Holdings L.P. ("Argos"). Argos is the sole common equity holder of Citrus Intermediate Holdings L.P. ("Citrus"). GP LLC is the general partner of Citrus. CIE Management IX Limited ("CIE") controls a majority of the equity interests of GP LLC and has the power to appoint members to the board of directors of GP LLC who may exercise majority voting power at meetings of the board of directors of GP LLC. BC Partners Holdings Limited is the controlling shareholder of CIE.
    3. The reported securities are held directly by affiliates and accounts managed by the Reporting Persons. Each Reporting Person may be deemed to be the beneficial owner of all or a portion of the securities reported herein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. On the basis of the relationship between each of Mr. Raymond Svider, Mr. Fahim Ahmed, Mr. Michael Chang and other directors of the Issuer designated or nominated by the Reporting Persons, the Reporting Persons may be directors of the Issuer by deputization for the purposes of Section 16 of the Exchange Act.
    /s/ Michael Chang, as Attorney-in-Fact for the Reporting Persons 06/26/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CHWY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHWY

    DatePrice TargetRatingAnalyst
    6/9/2025$47.00Outperform → Neutral
    Mizuho
    6/5/2025$43.00Buy → Hold
    Jefferies
    3/24/2025Neutral
    Seaport Research Partners
    1/23/2025Hold → Buy
    Argus
    1/13/2025$34.00 → $47.00In-line → Outperform
    Evercore ISI
    1/6/2025$24.00 → $42.00Neutral → Outperform
    Mizuho
    1/3/2025Peer Perform → Outperform
    Wolfe Research
    12/5/2024Outperform → Neutral
    Exane BNP Paribas
    More analyst ratings

    $CHWY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Chewy, Inc. Announces Pricing of Upsized Offering of Class A Common Stock by Selling Stockholder and Concurrent Repurchase

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today the pricing of an upsized underwritten public offering of 23,952,096 shares of its Class A common stock, par value $0.01 per share, by Buddy Chester Sub LLC (the "Selling Stockholder"), which is an entity affiliated with funds advised by BC Partners PE, LP ("BC Partners"), Chewy's largest shareholder, at a price to the public of $41.95 per share (the "Offering"). The Selling Stockholder granted the underwriter a 30-day option to purchase up to an additional 3,592,815 shares of Class A common stock. Chewy will not sell any shares of its Class A common stock in the Offering and wi

      6/23/25 9:40:00 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy, Inc. Announces Public Offering of Class A Common Stock by Selling Stockholder and Concurrent Share Repurchase

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today the commencement of an underwritten public offering of $1.0 billion of shares of its Class A common stock, par value $0.01 per share (the "Class A Common Stock"), by Buddy Chester Sub LLC (the "Selling Stockholder"), which is an entity affiliated with funds advised by BC Partners PE, LP ("BC Partners"), Chewy's largest shareholder (the "Offering"). The Selling Stockholder intends to grant the underwriters a 30-day option to purchase up to an additional $150.0 million of shares of Class A Common Stock. Chewy will not sell any shares of its Class A Common Stock in the Offering and

      6/23/25 4:19:00 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy Announces First Quarter 2025 Financial Results

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the first quarter of fiscal year 2025 ended May 4, 2025. Fiscal Q1 2025 Highlights: Net sales of $3.12 billion increased 8.3 percent year over year Gross margin of 29.6 percent decreased 10 basis points year over year Net income of $62.4 million, including share-based compensation expense and related taxes of $78.0 million Net margin of 2.0 percent decreased 30 basis points year over year Basic earnings per share of $0.15, consistent year over year Diluted earnings per share of $0.15, consistent year over year Adjusted EBITDA(1) of $

      6/11/25 7:05:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Star James A bought $249,519 worth of shares (12,242 units at $20.38), increasing direct ownership by 9% to 141,790 units (SEC Form 4)

      4 - Chewy, Inc. (0001766502) (Issuer)

      12/18/23 4:09:39 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Star James A bought $300,992 worth of shares (15,353 units at $19.60), increasing direct ownership by 13% to 129,548 units (SEC Form 4)

      4 - Chewy, Inc. (0001766502) (Issuer)

      12/14/23 4:10:59 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Chewy downgraded by Mizuho with a new price target

      Mizuho downgraded Chewy from Outperform to Neutral and set a new price target of $47.00

      6/9/25 7:45:18 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy downgraded by Jefferies with a new price target

      Jefferies downgraded Chewy from Buy to Hold and set a new price target of $43.00

      6/5/25 7:33:11 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Seaport Research Partners initiated coverage on Chewy

      Seaport Research Partners initiated coverage of Chewy with a rating of Neutral

      3/24/25 7:44:34 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Argos Holdings Gp Llc converted options into 29,940,120 shares and sold $1,250,000,010 worth of shares (29,940,120 units at $41.75) (SEC Form 4)

      4 - Chewy, Inc. (0001766502) (Issuer)

      6/26/25 4:05:06 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chief Executive Officer Singh Sumit sold $8,826,525 worth of shares (208,090 units at $42.42), decreasing direct ownership by 30% to 497,162 units (SEC Form 4)

      4 - Chewy, Inc. (0001766502) (Issuer)

      5/20/25 4:10:06 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chief Executive Officer Singh Sumit sold $8,056,695 worth of shares (198,806 units at $40.53), decreasing direct ownership by 22% to 705,252 units (SEC Form 4)

      4 - Chewy, Inc. (0001766502) (Issuer)

      5/15/25 4:44:06 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    SEC Filings

    See more
    • SEC Form 8-K filed by Chewy Inc.

      8-K - Chewy, Inc. (0001766502) (Filer)

      6/25/25 4:05:19 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form 424B7 filed by Chewy Inc.

      424B7 - Chewy, Inc. (0001766502) (Filer)

      6/24/25 4:05:44 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form FWP filed by Chewy Inc.

      FWP - Chewy, Inc. (0001766502) (Subject)

      6/24/25 6:05:10 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

      For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

      12/14/23 9:00:20 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    Leadership Updates

    Live Leadership Updates

    See more
    • Chewy Set to Join S&P MidCap 400

      NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Chewy Inc. (NYSE: CHWY) will replace Stericycle Inc. (NASD: SRCL) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 6. S&P 500 constituent Waste Management Inc. (NYSE:WM) is acquiring Stericycle in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 6, 2024 S&P MidCap 400 Addition Chewy CHWY Consumer Discretionary November 6, 2024 S&P MidCap 400 Deletion Stericycle SRCL Industrial For more information about

      11/1/24 7:11:00 PM ET
      $CHWY
      $SPGI
      $SRCL
      $WM
      Catalog/Specialty Distribution
      Consumer Discretionary
      Finance: Consumer Services
      Finance
    • Chewy Appoints Mark Eamer as Chief Marketing Officer

      Seasoned Leader to Spearhead Continued Expansion of Chewy's Marketing and Customer Engagement Capabilities Chewy, Inc. ("Chewy") (NYSE:CHWY), a leading online destination for pet parents and partners, announced today the appointment of Mark Eamer as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210930005601/en/Chewy Appoints Mark Eamer as Chief Marketing Officer (Photo: Business Wire) As CMO, Mark will spearhead the continued expansion of Chewy's Marketing and Customer Engagement capabilities, with ownership of the company's marketing strategy, partnerships and analytics, including full funnel cus

      9/30/21 9:00:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • GameStop Announces Additional Board Refreshment to Accelerate Transformation

      Aligns with Ryan Cohen of RC Ventures on the Immediate Appointment of Three New Directors with Significant E-Commerce and Technology Experience Confirms the Board’s Commitment to Supporting GameStop’s Pursuit of Growth and Market Leadership GRAPEVINE, Texas, Jan. 11, 2021 (GLOBE NEWSWIRE) -- GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today announced that it has entered into an agreement with RC Ventures LLC (“RC Ventures”) that will advance the refreshment of the Company’s Board of Directors (the “Board”). RC Ventures, which is one of the Company’s largest stockholders, is managed by Ryan Cohen. The agreement provides for the immediate appointment of three new directors –

      1/11/21 7:30:00 AM ET
      $CHWY
      $GME
      Catalog/Specialty Distribution
      Consumer Discretionary
      Electronics Distribution

    $CHWY
    Financials

    Live finance-specific insights

    See more
    • Chewy Announces First Quarter 2025 Financial Results

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the first quarter of fiscal year 2025 ended May 4, 2025. Fiscal Q1 2025 Highlights: Net sales of $3.12 billion increased 8.3 percent year over year Gross margin of 29.6 percent decreased 10 basis points year over year Net income of $62.4 million, including share-based compensation expense and related taxes of $78.0 million Net margin of 2.0 percent decreased 30 basis points year over year Basic earnings per share of $0.15, consistent year over year Diluted earnings per share of $0.15, consistent year over year Adjusted EBITDA(1) of $

      6/11/25 7:05:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy Announces Fiscal First Quarter 2025 Financial Results Conference Call

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal first quarter 2025 financial results before the market opens on Wednesday, June 11, 2025. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live audio webcast can be accessed

      5/9/25 8:30:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy Announces Fiscal Fourth Quarter and Full Year 2024 Financial Results

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the fiscal fourth quarter and full year 2024 ended February 2, 2025. Fiscal Q4 2024 Results (1): Net sales of $3.25 billion improved 14.9 percent year over year Gross margin of 28.5 percent expanded 30 basis points year over year Net income of $22.8 million, including share-based compensation expense and related taxes of $99.7 million Net margin of 0.7 percent declined 40 basis points year over year Basic earnings per share of $0.06, a decrease of $0.01 year over year Diluted earnings per share of $0.05, a decrease of $0.02 year over year Ad

      3/26/25 7:05:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Chewy Inc.

      SC 13G/A - Chewy, Inc. (0001766502) (Subject)

      11/12/24 2:29:11 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Chewy Inc.

      SC 13G/A - Chewy, Inc. (0001766502) (Subject)

      11/6/24 4:39:56 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Chewy Inc.

      SC 13G/A - Chewy, Inc. (0001766502) (Subject)

      11/4/24 11:23:07 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary